The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
O-GlcNAc modification blocks the aggregation and toxicity of the protein α-synuclein associated with Parkinson's disease
Open accessAbstract
Several aggregation-prone proteins associated with neurodegenerative diseases can be modified by O-linked N-acetyl-glucosamine (O-GlcNAc) in vivo. One of these proteins, α-synuclein, is a toxic aggregating-protein associated with synucleinopathies, including Parkinson’s disease. However, the effect of O-GlcNAcylation on α-synuclein is not clear. Here, we use synthetic protein chemistry to generate both unmodified α-synuclein and α-synuclein bearing a site-specific O-GlcNAc modification at the physiologically-relevant threonine residue 72. We show that this single modification has a notable and substoichiometric inhibitory-effect on α-synuclein aggregation, whilst not affecting the membrane binding or bending properties of α-synuclein. O-GlcNAcylation is also shown to affect the phosphorylation of α-synuclein in vitro and block the toxicity of α-synuclein that was exogenously added to cells in culture. These results suggest that increasing O-GlcNAcylation may slow the progression of synucleinopathies and further support a general function for O-GlcNAc in preventing protein aggregation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The many faces of α-synuclein: from structure and toxicity to therapeutic target
Lashuel, H. A., Overk, C. R., Oueslati, A., & Masliah, E. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3406 · Cited by 1,622
Spreading of pathology in neurodegenerative diseases: a focus on human studies
Brettschneider, J., Tredici, K. D., Lee, V. M.-Y., & Trojanowski, J. Q. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3887 · Cited by 790
O-GlcNAcylation regulates phosphorylation of tau: A mechanism involved in Alzheimer's disease
Liu, F., Iqbal, K., Grundke-Iqbal, I., Hart, G. W., & Gong, C.-X. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400348101 · Cited by 775 · cited 1×
“Several aggregation-prone proteins that directly contribute to neurodegeneration are themselves modified by O-GlcNAc, including tau 6,7 and α -synuclein 8,9 .”
A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo
Yuzwa, S. A., Macauley, M. S., Heinonen, J. E., Shan, X., Dennis, R. J., He, Y., Whitworth, G. E., Stubbs, K. A., McEachern, E. J., Davies, G. J., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.96 · Cited by 717 · cited 1×
“Increasing O-GlcNAcylation in vivo using small-molecule inhibitors of OGA has been shown to reduce hyperphosphorylation of tau in healthy rats 10 and slow neurodegeneration in a mouse model of Alzheimer’s disease 11 .”
Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation
Yuzwa, S. A., Shan, X., Macauley, M. S., Clark, T., Skorobogatko, Y., Vosseller, K., & Vocadlo, D. J. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.797 · Cited by 611
A little sugar goes a long way: The cell biology of O-GlcNAc
Bond, M. R., & Hanover, J. A. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201501101 · Cited by 568
The fold of α-synuclein fibrils
Vilar, M., Chou, H.-T., Lührs, T., Maji, S. K., Riek-Loher, D., Verel, R., Manning, G., Stahlberg, H., & Riek, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712179105 · Cited by 541
Blanco‐Canosa, J. B., & Dawson, P. E. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200705471 · Cited by 512
The Aggregation and Fibrillation of α-Synuclein
Fink, A. L. (2006) · Accounts of Chemical Research · doi:10.1021/ar050073t · Cited by 501
Jao, C. C., Hegde, B. G., Chen, J., Haworth, I. S., & Langen, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807826105 · Cited by 497
Self-citationO'Donnell, N., Zachara, N. E., Hart, G. W., & Marth, J. D. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.4.1680-1690.2004 · Cited by 431
Nutrient Regulation of Signaling, Transcription, and Cell Physiology by O-GlcNAcylation
Hardivillé, S., & Hart, G. W. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.07.014 · Cited by 402
Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion‐Like Disorder?
Olanow, C. W., & Brundin, P. (2013) · Movement Disorders · doi:10.1002/mds.25373 · Cited by 390
Paleologou, K. E., Schmid, A. W., Rospigliosi, C. C., Kim, H.-Y., Lamberto, G. R., Fredenburg, R. A., Lansbury, P. T., Fernandez, C. O., Eliezer, D., Zweckstetter, M., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800747200 · Cited by 363
Oueslati, A., Fournier, M., & Lashuel, H. A. (2010) · Progress in Brain Research · doi:10.1016/s0079-6123(10)83007-9 · Cited by 347
Paleologou, K. E., Oueslati, A., Shakked, G., Rospigliosi, C. C., Kim, H.-Y., Lamberto, G. R., Fernandez, C. O., Schmid, A., Chegini, F., Gai, W. P., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5922-09.2010 · Cited by 324
Synucleins Regulate the Kinetics of Synaptic Vesicle Endocytosis
Vargas, K. J., Makani, S., Davis, T., Westphal, C. H., Castillo, P. E., & Chandra, S. S. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4787-13.2014 · Cited by 320
Membrane Curvature Induction and Tubulation Are Common Features of Synucleins and Apolipoproteins
Varkey, J., Isas, J. M., Mizuno, N., Jensen, M. B., Bhatia, V. K., Jao, C. C., Petrlova, J., Voss, J. C., Stamou, D. G., Steven, A. C., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.139576 · Cited by 319
Self-citationAlfaro, J. F., Gong, C.-X., Monroe, M. E., Aldrich, J. T., Clauss, T. R. W., Purvine, S. O., Wang, Z., Camp, D. G., Shabanowitz, J., Stanley, P., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200425109 · Cited by 300
The Emerging Link between O-GlcNAc and Alzheimer Disease
Zhu, Y., Shan, X., Yuzwa, S. A., & Vocadlo, D. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.601351 · Cited by 267
Wang, Z., Udeshi, N. D., O'Malley, M., Shabanowitz, J., Hunt, D. F., & Hart, G. W. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900268-mcp200 · Cited by 261
The Role of Stable α-Synuclein Oligomers in the Molecular Events Underlying Amyloid Formation
Lorenzen, N., Nielsen, S. B., Buell, A. K., Kaspersen, J. D., Arosio, P., Vad, B. S., Paslawski, W., Christiansen, G., Valnickova-Hansen, Z., Andreasen, M., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja411577t · Cited by 255
Yuzwa, S. A., & Vocadlo, D. J. (2014) · Chem. Soc. Rev. · doi:10.1039/c4cs00038b · Cited by 247
Phosphorylation of Synucleins by Members of the Polo-like Kinase Family
Mbefo, M. K., Paleologou, K. E., Boucharaba, A., Oueslati, A., Schell, H., Fournier, M., Olschewski, D., Yin, G., Zweckstetter, M., Masliah, E., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081950 · Cited by 246
Investigation of α-Synuclein Fibril Structure by Site-directed Spin Labeling
Chen, M., Margittai, M., Chen, J., & Langen, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700368200 · Cited by 233
Self-citationEffect of the overexpression of wild‐type or mutant α‐synuclein on cell susceptibility to insult
Lee, M., Hyun, D., Halliwell, B., & Jenner, P. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00149.x · Cited by 232
Lefebvre, T., Ferreira, S., Dupont-Wallois, L., Bussière, T., Dupire, M.-J., Delacourte, A., Michalski, J.-C., & Caillet-Boudin, M.-L. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00477-4 · Cited by 209
Clinical overview of the synucleinopathies
Mart�, M. J., Tolosa, E., & Campdelacreu, J. (2003) · Movement Disorders · doi:10.1002/mds.10559 · Cited by 203
Oueslati, A., Schneider, B. L., Aebischer, P., & Lashuel, H. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309991110 · Cited by 203
Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity
Tabrizi, S. J. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.18.2683 · Cited by 197
Alpha-synuclein spreading in Parkinson’s disease
Recasens, A., & Dehay, B. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00159 · Cited by 180
The H50Q Mutation Enhances α-Synuclein Aggregation, Secretion, and Toxicity
Khalaf, O., Fauvet, B., Oueslati, A., Dikiy, I., Mahul-Mellier, A.-L., Ruggeri, F. S., Mbefo, M. K., Vercruysse, F., Dietler, G., Lee, S.-J., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.553297 · Cited by 179
Fauvet, B., Fares, M.-B., Samuel, F., Dikiy, I., Tandon, A., Eliezer, D., & Lashuel, H. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.383711 · Cited by 169
Cheung, W. D., Sakabe, K., Housley, M. P., Dias, W. B., & Hart, G. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806199200 · Cited by 162
Burai, R., Ait-Bouziad, N., Chiki, A., & Lashuel, H. A. (2015) · Journal of the American Chemical Society · doi:10.1021/ja5131726 · Cited by 161
Haj‐Yahya, M., Fauvet, B., Herman-Bachinsky, Y., Hejjaoui, M., Bavikar, S. N., Karthikeyan, S. V., Ciechanover, A. J., Lashuel, H. A., & Brik, A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315654110 · Cited by 156
Site-Specific GlcNAcylation of Human Erythrocyte Proteins
Wang, Z., Park, K., Comer, F. I., Hsieh‐Wilson, L. C., Saudek, C. D., & Hart, G. W. (2008) · Diabetes · doi:10.2337/db08-0994 · Cited by 152
α‐Synuclein: The Long Distance Runner
George, S., Rey, N. L., Reichenbach, N., Steiner, J. A., & Brundin, P. (2013) · Brain Pathology · doi:10.1111/bpa.12046 · Cited by 135
Boassa, D., Berlanga, M. L., Yang, M. A., Terada, M., Hu, J., Bushong, E. A., Hwang, M., Masliah, E., George, J. M., & Ellisman, M. H. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2898-12.2013 · Cited by 135
O-GlcNAcylation Prevents Aggregation of the Polycomb Group Repressor Polyhomeotic
Gambetta, M. C., & Müller, J. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.10.020 · Cited by 133
Mapping O-GlcNAc modification sites on tau and generation of a site-specific O-GlcNAc tau antibody
Yuzwa, S. A., Yadav, A. K., Skorobogatko, Y., Clark, T., Vosseller, K., & Vocadlo, D. J. (2011) · Amino Acids · doi:10.1007/s00726-010-0705-1 · Cited by 130
Hejjaoui, M., Haj‐Yahya, M., Kumar, K. S. A., Brik, A., & Lashuel, H. A. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201005546 · Cited by 130
Hejjaoui, M., Butterfield, S. M., Fauvet, B., Vercruysse, F., Cui, J., Dikiy, I., Prudent, M., Olschewski, D., Zhang, Y., Eliezer, D., et al. (2012) · Journal of the American Chemical Society · doi:10.1021/ja210866j · Cited by 122
Mizuno, N., Varkey, J., Kegulian, N. C., Hegde, B. G., Cheng, N., Langen, R., & Steven, A. C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.365817 · Cited by 119
Self-citationHigh Stability and Cooperative Unfolding of α-Synuclein Oligomers
Pasławski, W., Andreasen, M., Nielsen, S. B., Lorenzen, N., Thomsen, K., Kaspersen, J. D., Pedersen, J. S., & Otzen, D. E. (2014) · Biochemistry · doi:10.1021/bi5007833 · Cited by 73
Emanuele, M., & Chieregatti, E. (2015) · Biomolecules · doi:10.3390/biom5020865 · Cited by 69
O‐GlcNAc Modification Prevents Peptide‐Dependent Acceleration of α‐Synuclein Aggregation
Marotta, N. P., Cherwien, C. A., Abeywardana, T., & Pratt, M. R. (2012) · ChemBioChem · doi:10.1002/cbic.201200478 · Cited by 68
Self-citationPitfalls associated with the use of Thioflavin-T to monitor anti-fibrillogenic activity
Cerqueira, E. C., Pinheiro, A. S., & Follmer, C. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.04.072 · Cited by 61
Ko, L., Ko, H.-H. C., Lin, W.-L., Kulathingal, J. G., & Yen, S.-H. C. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31818c3618 · Cited by 50
Koo, H.-J., Choi, M. Y., & Im, H. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.002 · Cited by 18
Cited by
Protein O-GlcNAcylation: emerging mechanisms and functions
Yang, X., & Qian, K. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.22 · Cited by 1,194
Zhong, Q., Xiao, X., Qiu, Y., Xu, Z., Chen, C., Chong, B., Zhao, X., Hai, S., Li, S., An, Z., et al. (2023) · MedComm · doi:10.1002/mco2.261 · Cited by 442
Snead, W. T., & Gladfelter, A. S. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.09.016 · Cited by 352
Role of O-linked N-acetylglucosamine protein modification in cellular (patho)physiology
Chatham, J. C., Zhang, J., & Wende, A. R. (2021) · Physiological Reviews · doi:10.1152/physrev.00043.2019 · Cited by 352
Nutrient regulation of signaling and transcription
Hart, G. W. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.aw119.003226 · Cited by 345
Metadata
- Authors
- Marotta, N. P., Lin, Y. H., Lewis, Y. E., Ambroso, M. R., Zaro, B. W., Roth, M. T., Arnold, D. B., Langen, R., & Pratt, M. R.
- Venue
- Nature Chemistry
- Published
- 2015-10-12
- Volume
- 7
- Issue
- 11
- Pages
- 913-920
- ISSN
- 1755-4330 (ISSN-L)
- 1755-4349
- OpenAlex
- W2119333160
- Cited by
- 301
- References
- 50
- FWCI
- 11.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.